510(k) Report

510(k) · Cleared

Recalled · Class II · 2019

Aquilion One Version 4.6 W/Dual Energy Scan System, Model TSX-301A/2

K093891510(k) AbbreviatedCleared Nov 18, 2010335-day reviewClass II21 CFR 892.1750Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Toshibamedical Systems Corporation · JAK System, X-Ray, Tomography, Computed

Cleared on Nov 18, 2010 after a 335-day review. The FDA summary names no predicate by number. 15 later devices descend from it. It has been recalled once.

Decided
Nov 18, 2010
Review
335 days
Class
Class II
Product code
JAK
Recalls
1
Predicates
0

15 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2012: 2 descendants cleared2015: 1 descendant cleared2019: 1 descendant cleared2016: 1 descendant cleared2017: 2 descendants cleared2021: 2 descendants cleared2020: 2 descendants cleared2023: 3 descendants cleared2026: 1 descendant cleared2010201520202025
  1. This deviceK093891 Aquilion One Version 4.6 W/Dual Energy Scan System, Model TSX-301A/2Toshibamedical Systems Corporation · 2010
  2. Descendant · cites it directly · 13 of its ownK121553 Aquilion RXLToshibamedical Systems Corporation · 2012 · Recalled
  3. Descendant · 2 generations on · 11 of its ownK151833 Aquilion Lightning (TSX-035A/2, V7.0)Toshibamedical Systems Corporation · 2015 · Recalled
  4. Descendant · 3 generations on · 10 of its ownK153263 Aquilion Lightning, TSX-035A/4 and /5, V7.0Toshibamedical Systems Corporation · 2016
  5. Descendant · 4 generations on · 9 of its ownK170019 Aquilion Lightning, TSX-036A/1, V8.4Toshibamedical Systems Corporation · 2017 · Recalled
  6. Descendant · 5 generations on · 4 of its ownK201836 Aquilion Lightning (TSX-036A/7) V10.2 with AiCE-iCanon Medical Systems Corporation · 2021

Showing 5 of 15 descendants. See all descendants

Descendants cleared per year

2012: 22015: 12016: 12017: 22019: 12020: 22021: 22023: 32026: 1
2012high 3 (2023) · low 0 (2013)2026

Most influential descendants

Showing 5 of 15 · See all
  • K121553Aquilion RXLToshibamedical Systems Corporation · 2012 · cites it directly13descendants
  • K151833Aquilion Lightning (TSX-035A/2, V7.0)Toshibamedical Systems Corporation · 2015 · 2 generations on11descendants
  • K153263Aquilion Lightning, TSX-035A/4 and /5, V7.0Toshibamedical Systems Corporation · 2016 · 3 generations on10descendants
  • K170019Aquilion Lightning, TSX-036A/1, V8.4Toshibamedical Systems Corporation · 2017 · 4 generations on9descendants
  • K201836Aquilion Lightning (TSX-036A/7) V10.2 with AiCE-iCanon Medical Systems Corporation · 2021 · 5 generations on4descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K093891Aquilion One Version 4.6 W/Dual Energy Scan System, Model TSX-301A/2Toshibamedical Systems Corporation2010—
+1K121553Aquilion RXLToshibamedical Systems Corporation20121
+2K151833Aquilion Lightning (TSX-035A/2, V7.0)Toshibamedical Systems Corporation20151
+3K153263Aquilion Lightning, TSX-035A/4 and /5, V7.0Toshibamedical Systems Corporation2016—
+4K170019Aquilion Lightning, TSX-036A/1, V8.4Toshibamedical Systems Corporation20171
+5K201836Aquilion Lightning (TSX-036A/7) V10.2 with AiCE-iCanon Medical Systems Corporation2021—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201220
201510
201610
201720
201910
202020
202120
202330
202610
FIG. 1 — Lineage of K093891, 2010–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JAK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JAK device

  1. #1 K230223 iCAC Devicescore 23.5 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

The FDA summary names no predicate by number.

What descends from it? (15)

See all 15

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K121553Aquilion RXLToshibamedical Systems Corporation201213
K110066Aquilion PrimeToshiba America Medical Systems, In.C20120

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Mar 25, 2019Class IIZ-1720-2020Software designScanning may be interrupted due to an error during execution of the eXam Plan and the system is unable to be shut down normally, resulting in the need to forcibly turn the system power off and reboot. Loss of the acquired raw data would…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K121553 (Toshibamedical Systems Corporation, 2012) has gone furthest, with 13 descendants of its own.

How does its category compare?

All JAK devices

JAK System, X-Ray, Tomography, Computed: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · JAK

27in 2025

2007: 142008: 262009: 152010: 72011: 162012: 282013: 172014: 302015: 302016: 252017: 292018: 242019: 282020: 302021: 202022: 302023: 272024: 262025: 272026 (partial year): 21
2007high 30 (2014) · low 7 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JAK

141in 2025

2007: 27 days median2008: 42 days median2009: 31 days median2010: 92 days median2011: 155 days median2012: 121 days median2013: 132 days median2014: 200 days median2015: 140 days median2016: 129 days median2017: 96 days median2018: 114 days median2019: 94 days median2020: 112 days median2021: 145 days median2022: 131 days median2023: 139 days median2024: 141 days median2025: 141 days median2026 (partial year): 167 days median
2007high 200 (2014) · low 27 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JAK

17in 2025

2007: 112008: 162009: 292010: 512011: 342012: 232013: 112014: 102015: 282016: 442017: 332018: 102019: 52020: 82021: 152022: 92023: 92024: 202025: 172026 (partial year): 23
2007high 51 (2010) · low 5 (2019)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JAK

219in 2025

2007: 762008: 1202009: 1052010: 1192011: 2052012: 1922013: 4142014: 3082015: 4542016: 3652017: 3382018: 5432019: 2332020: 1772021: 2612022: 1992023: 3102024: 2122025: 219
2007high 543 (2018) · low 76 (2007)2025

MAUDE reports naming product code JAK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200714271176
2008264216120
2009153129105
201079251119
20111615534205
20122812123192
20131713211414
20143020010308
20153014028454
20162512944365
2017299633338
20182411410543
201928945233
2020301128177
20212014515261
2022301319199
2023271399310
20242614120212
20252714117219
20262116723—

What is it indicated for?

This device is indicated to acquire and display cross sectional volumes of the whole body, to include the head; with the capability of imaging whole organs in a single rotation. Whole organs include but are not limited to brain, heart, pancreas, etc, The Aquilion ONE has the capability to provide volume sets of the entire organ. These volume sets can then be used to perform specialized studies, using indicated software/hardware of the whole organ by a…

Read the full statement (126 words)

This device is indicated to acquire and display cross sectional volumes of the whole body, to include the head; with the capability of imaging whole organs in a single rotation. Whole organs include but are not limited to brain, heart, pancreas, etc,

The Aquilion ONE has the capability to provide volume sets of the entire organ. These volume sets can then be used to perform specialized studies, using indicated software/hardware of the whole organ by a trained and qualified physician.

The Dual Energy System has been designed to analyze the composition of body materials. The system can load two CT images scanned with two different tube voltages and analyze the composition of the target materials by using the energy dependence of the attenuation coefficients of materials.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K093891: Aquilion One Version 4.6 W/Dual Energy Scan System, Model TSX-301A/2.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K093891

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026